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A variety of biological events, including inflammatory responses, are subject to 
mechanical influence. However, it remains largely elusive how inflammation-
related signaling is mechanically modulated.  Here we show that p130Cas (Crk-
associated substrate, hereafter referred to as Cas), which has previously been 
reported to act as a cellular mechano-sensor, attenuates the activity of NF-κB, the 
key molecule in inflammatory signaling.  Upon treatment with the inflammatory 
cytokine TNF-α, Cas translocates into the nucleus and inhibits the acetylation of 
NF-κB, which is required for its full activation, by interfering with its physical 
association with the acetyltransferase p300.  In contrast, Cas does not affect the 
nuclear localization and phosphorylation of NF-κB, suggesting that Cas regulates 
the activity of NF-κB by inhibiting its acetylation in the nucleus.  
Osteocytes, which have been postulated as mechanosensory cells in bone, 
orchestrate the process of bone remodeling by secreting paracrine and systemic 
regulators that regulate the functions of both osteoblasts and osteoclasts. We 
therefore test if the mechanosensing molecule Cas plays a role in the response of 
osteocytes to mechanical loading/unloading. Osteocyte-specific Cas knockout 
mice exhibit an osteopenia associated with an increased osteoclastic bone 
resorption based on an enhanced RANKL expression. We find that an increased 
ROS production related to mitochondrial dysfunction is responsible for the 
increased RANKL expression in Cas-silenced osteocytes, which is reverted by 
knockdown of NF-κB (p65 subunit) expression. Consistently, genetic depletion of 
the mitochondrial transcription factor A expression in osteocytes leads to an 
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osteopenia, recapitulating the phenotype of osteocyte-specific Cas knockout mice. 
These results suggest that the Cas-NF-κB-mitochondria axis supports the normal 
bone metabolism, providing novel insights into therapeutic strategies for atrophic 
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Part I Cas-NF-κB interplay 
 
1.1 Introduction 
Mechanical cues regulate signal transduction and gene expression in various 
biological events, including inflammatory responses.  However, it remains 
largely unclear how inflammatory signals, such as the ones induced by 
cytokines and chemokines, are mechanically modulated.  Response of cells to 
those proinflammatory factors assures proper biological events and helps 
organisms grow or defend themselves against injury and infection. A number 
of physical disorders and diseases arise from abnormal inflammation-related 
signaling, which includes mechanically-inducible signal transduction, termed 
mechanotransduction. For example, mechanical unloading affects the 
regenerative process of skeletal muscle after injury that engages 
proinflammatory signaling events (Kohno et al., 2012). 
 
1.1.1 Inflammation 
1.1.1.1 Inflammation in Health Problems 
Inflammation involves a multifactorial network of biochemical signals in 
response to pathogens and noxious stimuli, such as chemicals or physical 
injuries, which impinge on tissues and cells.  In the case of acute 
inflammation, a series of events are immediately triggered including local 
increases in blood flow and capillary permeability, and additional circulating 
leukocytes are recruited through extravasation (Serhan, 2008).  It is a short-
term response that usually results in prompt healing; leukocytes infiltrate the 
damaged region, removing the stimulus and repairing the tissue. Chronic 





when the mechanisms of the pro-inflammatory signaling termination, which 
clear inflammatory cells, fail to restore normal tissue functions (Pawelec et al., 
2014). Such persistent inflammation is associated with many chronic human 
disorders and diseases, including allergy, atherosclerosis, cancer, arthritis and 
autoimmune diseases (Baecklund et al., 2006; Baniyash et al., 2014; Jongstra-
Bilen et al., 2006; Staikuniene et al., 2008). 
 
1.1.1.2 Nuclear Factor kappaB (NF-κB) 
Nuclear factor kappaB (NF-κB), which regulates inflammatory and immune 
responses as well as other processes of cell growth, survival or death, is a 
ubiquitously expressed transcription factor.  In 1986, it was first identified as a 
regulator of expression of the κB light chain in B cells. Years of extensive 
research on the function and regulation of NF-κB has promoted our 
understanding on its vital role in inflammation and immunity, and an ever-
expanding list of diseases involving dysfunction of NF-κB (Sen and 
Baltimore, 1986). Through its activity to bind to the 10-base pair κB sites 
located at gene enhancers, NF-κB regulates inducible gene expression, which 
is critical for normal organismal physiology and adaption to environmental 
changes, such as chemical and mechanical stresses (Hayden and Ghosh, 
2008).  
 In mammals, NF-κB consists of five subunits: RelA/p65, c-Rel, RelB, 
p50 (the processed form of p105), and p52 (the processed form of p100). 
These subunits contain a DNA-binding/dimerization domain and nuclear 
localization signal, but only RelA/p65 (hereafter referred to as p65), c-Rel, and 





the classical and the alternative pathways, regulate the nuclear translocation 
and activation of NF-κB. The classical pathway is common in all cell types 
whereas the alternative is mainly involved in T- and B-cell differentiation 
(Hayden and Ghosh, 2011). 
 External stimuli, such as inflammatory cytoskines or genotoxic agents, 
activate the classic NF-κB pathway. In an inactive state, NF-κB is associated 
with IκBs (the inhibitors of NF-κB). Activated upstream receptors induce IκB 
kinase (IKK) activation. The IKK complex consists of two catalytic subunits 
(IKKα, IKKβ) and a regulatory subunit (NEMO). Once activated, IKKα and 
IKKβ phosphorylate IκBs, leading to their degradation mediated by the 
ubiquitin-proteasome system, followed by the release of NF-κB subunits. The 
NF-κB dimers then translocate into nucleus, bind to the κB element and 
initiate the transcription of target genes (Figure 1.1). In addition to the IκB 
degradation and the subsequent nuclear translocation of NF-κB, there are 
several steps that are required for full transactivation of NF-κB-dependent 
gene expression. Numerous regulatory posttranslational modifications of NF-
κB have been reported, including their phosphorylation and acetylation, which 
alter IκB binding, affinity for κB sites, and their interactions with 





























Figure 1.1 A schematic diagram of the classical NF-κB signaling 
pathway. 
IKK activation results in IκB phosphorylation and degradation. The NF-
κB dimer (p65 and p50 subunits) is released and translocates into the 
nucleus binding to κB DNA elements to induce the transcription of its 
target genes. Posttranslational modifications of NF-κB, such as 




TNF-α is a cytokine that plays pivotal roles in inflammation under a variety of 
physiological and pathological circumstances, including developmental 
processes and immune responses. It activates the NF-κB signaling pathway, 
which regulates the expression of numerous mediators important for cell 
apoptosis, adhesion, malignant transformation, cell cycle control, immune 
responses, and embryonic development. TNF-α-induced NF-κB activation 





this tightly regulated process are implicated in the pathogenesis of many 
diseases. Especially due to its significant influence on inflammation and 
immune responses, TNF-α has been identified as a potential therapeutic target 
for a number of immune diseases, including rheumatoid arthritis (Keffer et al., 
1991), Crohn’s disease (Van Deventer, 1997), asthma (Berry et al., 2007), and 
psoriasis (Kircik and Del Rosso, 2009). 
 
1.1.2 Mechanical Regulation of Inflammation  
External mechanical stimulations, such as stretching and fluid shear stress, 
have been shown to exert beneficial or detrimental effects on the recovery of 
cells and tissues/organs from inflammation (Kim et al., 2014; Kippenberger et 
al., 2000; Wong et al., 2011). Moreover, cells are always under a certain 
mechanical condition provided by the surrounding (micro)environments that 
may have different mechanical characteristics. This also stipulates a scenario 
(or platform) for the inflammatory responses that may vary depending on the 
different mechanical characteristics of cells and substrates. Wound healing 
process exemplifies the mechanical regulation of inflammation. It has been 
shown that mechanical cues applied to cells is critical for the progression of 
normal wound healing through the inflammatory, proliferative, and 
remodeling phases of repair (Aarabi et al., 2007). 
 Previous studies have shown that the NF-κB activity is mechanically 
regulated (Kippenberger et al., 2000; Wong et al., 2011). To date, cellular 
stretching and fluid shear stress have been reported to activate the NF-κB 
signaling pathway in vitro (Hay et al., 2003; Inoh et al., 2002; Orr et al., 





mechanical stimuli and/or environments in regulating the NF-κB activity. For 
example, mechanical force can significantly modulate the NF-κB activation by 
TNF-α in the inflammatory processes on different occasions that include scar 
formation (Aarabi et al., 2007), arthritis (Kameyama et al., 2004) and 
atherosclerosis (Yamamoto et al., 2003). However, little is known about the 
molecules that respond to mechanical stimuli and modify the NF-κB activity.  
  
1.1.3 The Mechanosensor Protein Cas 
The adaptor molecule Cas, which is phosphorylated at focal adhesions upon 
extracellular matrix engagement, is involved in various cellular processes 
including migration, survival, transformation, and differentiation 
(Tikhmyanova et al., 2010). 
1.1.3.1 Structure 
As shown in Figure 1.2, Cas is a scaffold protein containing the following 
functional domains; N-terminal SH3 domain that interacts with focal adhesion 
kinase (FAK), proline-rich region (Pro), central substrate domain (SD), serine-
rich region (Ser), Src-binding domain (SBD) and conserved C-terminal region 




Figure 1.2 Domain structure of a Cas protein. 
PTB: phospho-tyrosine binding domain; HLH: helix-loop-helix motif. 







Serving as a scaffold protein that participates in various intracellular signaling 
events, Cas acts as a cell mechano-sensor that plays important roles in the 
response to extracellular matrix (ECM) rigidity (Kostic and Sheetz, 2006) and 
cellular stretching (Sawada et al., 2006). It was primarily described as a focal 
adhesion protein (Sakai et al., 1994), as it localizes and functions at cell-
matrix adhesion sites, interacting with focal adhesion kinase (FAK) and 
undergoing the substrate domain (CasSD) tyrosine phosphorylation by Src 
family kinases (SFKs). Binding to FAK and SFK through the SH3 and Src-
binding domains, respectively, provides Cas with anchors to focal adhesions, 
allowing the CasSD to be physically extended upon stretching of the substrate 
to which cells adhere. The extension of CasSD makes it more accessible to 
SFKs, and enhances its phosphorylation, thereby facilitating the downstream 
signaling (Sawada et al., 2006). Phosphorylation of Cas at focal adhesions 
mediates the recruitment of the Crk-DOCK180 complex that leads to 
activation of the small GTPase Rac (Cho and Klemke, 2002). 
 
Figure 1.3 Mechano-sensing through physical extension of the 
substrate domain of Cas. 
The physical extension of the substrate domain of Cas facilitates its 







1.1.4 Hypothesis on the Interplay Between Cas and NF-κB 
Previous reports have implied a potential link between Cas and NF-κB. The 
signaling pathway mediated by Cas phosphorylation might induce NF-κB 
activation through the small GTPase Rac (Cho and Klemke, 2002; Williams et 
al., 2008). Based on these studies, we initially hypothesized that Cas might 
interact with NF-κB to regulate its activity.  However, we found that an 
opposite scenario appeared to be the case, as we proceeded with our analysis.  
 Since NF-κB can be mechanically activated, there may also be a 
mechanically activatable signaling pathway that inactivates NF-κB; otherwise 
the balance of mechanical regulation of NF-κB activity would be disrupted. 
Nonetheless, such an NF-κB-inactivating mechanical signal has not been 
found. In this study we explored the potential regulatory role of Cas in 
inflammation through its negative effect on NF-κB activity. TNF-α was used 
as an inducer of NF-κB activation, and human embryonic kidney (HEK) 293 
cells were used as an experimental tool in the analysis of molecular 
interactions because of the ease of exogenous gene expression as well as their 






1.2 Material and Methods 
1.2.1 Cell Culture 
HEK293 cells were cultured in DMEM (Dulbecco’s modified Eagle’s medium, 
Nissui Pharmaceutical) supplemented with 10% fetal bovine serum (FBS, Life 
Technologies) and penicillin/streptomycin (100 IU/ml and 100 μg/ml) at 37°C. 
1.2.2 Chemicals and Reagents 
TNF-α was purchased from Peprotech (Rocky Hill, NJ, US). Swine Type I 
collagen was purchased from Nitta Gelatin Inc. (Osaka, Japan). Protease 
inhibitor cocktail was purchased from Roche (Mannheim, Germany).  Other 
chemicals, including HDAC inhibitor SAHA and p300 inhibitor C646, were 
purchased from Sigma. 
1.2.3 Plasmids and Antibodies 
Expression vectors for p65 (pcDNA3-FLAG-p65 and pcDNA3-HA-p65) were 
previously described (Kawauchi et al., 2008). The expression vectors for 
FLAG-tagged Cas variants (Cas full-length, Cas15YF, Cas1-457, Cas1-638, 
Cas1-671, Cas1-738, Cas458-874, Cas639-874, Cas672-874 and Cas739-874) 
were constructed using pcDNA3 as a parent vector. The expression vector for 
p300 (CMVβ-p300-HA) was a gift from Dr. Yamamoto (Hassa et al., 2005). 
Plasmids pNF-κB-luc and pRL-TK were gifts of Dr. Keiko (Kawauchi et al., 
2012). The expression vector for NES-Cas was constructed by cloning an NES 
sequence (MNLVDLQKKLEELELDEQQ) attached Cas into pcDNA3 (Araki 
et al., 2013). 
Polyclonal anti-Cas antibody (αCas3) was reported previously (Sawada et al., 
2006). Monoclonal anti-Cas antibody was purchased from BD Biosciences 





antibodies were purchased from Invitrogen and Abcam, and Covance 
respectively. Monoclonal anti-p65, anti-GAPDH, anti-HSP90, and anti-p300 
were purchased from Santa Cruz. Polyclonal anti-phospho-p65 (serine 536), 
monoclonal anti-HSP90, monoclonal anti-histone H3 and polyclonal anti-
acetylated-p65 (lysine 310) were purchased from Cell Signaling.  
1.2.4 Luciferase Reporter Assay 
NF-κB-responsive reporter plasmid (pNF-κB-luc) and Renilla luciferase 
expression plasmid (pRL-TK) were cotransfected with the indicated 
expression plasmids into HEK293 cells. 24 hours after transfection cells were 
assayed for luciferase activity using Dual-Glo assay kits (Promega).  In the 
case of experiments involving TNF-α, cells were treated with TNF-α (10 
ng/ml) for 8 hours before being lysed. Afterwards, cells, and luciferase 
expression was analyzed. Specific κB-luc activity in individual samples was 
determined by normalizing Firefly luciferase activity to Renilla luciferase 
activity. For all assays, experiments were performed in triplicate.  
1.2.5 RNA Interference Experiment 
Cas-targeted siRNA was reported previously. Control siRNA was purchased 
from Santa Cruz. HEK293 cells were reverse-transfected with siRNAs (final 
concentration: 10 nM) using Lipofectamine RNAiMAX according to 
manufacturer’s recommendations.  
1.2.6 RNA Extraction and qRT-PCR 
Total RNA was isolated using a RNA extraction kit (OMEGA Bio-Tech), and 
cDNA, obtained using the first strand cDNA synthesis kit (Fermentas), was 





CFX96 C1000 Thermal Cycler (Bio-Rad). The level of target gene expression 
was normalized against β-actin expression. 
1.2.7 Cellular Fractionation 
The cytosolic and nuclear fractions were prepared as previously described 
with a slight modification (Schreiber et al., 1989). Cells were washed with ice 
cold PBS twice, incubated with Buffer A (10mM Hepes.Na pH7.9, 10mM 
KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% NP-40, 1 mM DTT, 1 mM 
Na3VO4, 10 mM NaF, protease inhibitor cocktail) on ice for 10 min, and then 
scraped and harvested. The cytosolic fraction was yielded by collecting the 
supernatant after centrifugation at 500 x g for 3 min. The pellet was washed 
with Wash Buffer (10mM Hepes.Na pH7.9, 10mM KCl, 0.1 mM EDTA, 0.1 
mM EGTA, 1 mM DTT, 1 mM Na3VO4, 10 mM NaF, protease inhibitor 
cocktail) twice, and the resultant pellet was resuspended in Buffer B (20mM 
Hepes.Na pH7.9, 500 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 
mM Na3VO4, 10 mM NaF, protease inhibitor cocktail), incubated on ice for 
15 min, and rigorously mixed by vortex. The nuclear fraction was yielded by 
collecting the supernatant after centrifugation at 20,000 x g for 10min. 
1.2.8 Co-Immunoprecipitation 
For co-immunoprecipitation experiments, HEK293 cells grown in a 24-well 
plate were washed with ice-cold PBS, lysed with p300/p65 complex extraction 
buffer (25mM Hepes.Na, pH 7.2, 150 mM CH3COOK, 2mM EDTA, 0.1% 
NP-40, 10 nM NaF, protease inhibitor cocktail) (Gerritsen et al., 1997), 
scraped, and collected in a tube. After 10 min incubation on ice, samples were 
cleared of cell debris by centrifugation at 13,000g for 10 min, and incubated 





Protein A Magnetic Beads (Millipore) according to the manufacturer’s 
instruction, and proteins were recovered from resultant immunoprecipitates by 
1 x SDS sample buffer and subjected to SDS-PAGE followed by 
immunoblotting. 
1.2.9 Immunofluorescence Staining 
Immunofluorescence staining was performed as described previously(Hirata et 
al., 2008). Cells were washed with ice-cold PBS; fixed with 4% 
paraformaldehyde in PBS; permeabilized with 0.1% Triton X-100 in PBS; 
incubated with primary antibodies and Alexa Fluor 488 anti-rabbit IgG or 
Alexa Fluor 546 anti-mouse IgG (Invitrogen) as a secondary antibody; and 
then viewed with a confocal microscope (Nikon A1R). DAPI (Vector 
Laboratories) was used to stain the nucleus. 
1.2.10 Chromatin Immunoprecipitation (CHIP) Assay  
HEK293 cells were transfected with Cas-targeted or control-siRNA as 
described above. 24 hours after transfection, cells were treated with or without 
TNF-α (10 ng/ml) for 2 hours, washed with PBS, and incubated with 1% 
formaldehyde in the culture media for 10 minutes to cross-link DNA with 
proteins. CHIP assay was performed using a kit from Millipore according to 
manufacturer’s instruction. The activity to binding to the κB region was 
measured by conducting qPCR analysis of the immunoprecipitates as 
previously described (El Gazzar et al., 2009). 
1.2.11 Primer Sequences Used for Real-time PCR Analysis 
Primer sequences used were as follows. Human IL-8: 5’- 
CTTGGCAGCCTTCCTGATTT-3’ and 5’-





TCTTCTCGAACCCCGAGTGA-3’ and 5’- CCTCTGATGGCACCACCAG-
3’, human β-actin: 5’-GTACCACTGGCATCGTGATGGACT-3’ and 5’- 
CCGCTCATTGCCAATGGTGAT-3’.The primers used to amplify a sequence 
in the human TNF-α proximal promoter region containing the κB site at -98 bp 
relative to the transcription start site were: 5’-
TACCGCTTCCTCCAGATGAG-3’ and 5’-TGCTGGCTGGGTGTGCCAA-
3’(El Gazzar et al., 2009). 
1.2.12 Statistics 
Statistical analyses were performed using a 2-tailed unpaired Student’s t test, 
and each series of experiments was repeated at least 3 times. Results are 







1.3.1 Cas Negatively Regulates NF-κB Activity 
To gain an insight into Cas-mediated regulation of inflammatory responses 
that involve NF-κΒ, we first examined if Cas modulated NF-κB transcriptional 
activity by conducting a luciferase assay using an NF-κB-responsive luciferase 
reporter in the co-expression of Cas and NF-κB p65 subunit. We found that 
the activity of NF-κB decreased when it was co-transfected with Cas (Figure 
1.4A). Furthermore, the expressions of NF-κB target genes, IL-8 and TNF-α, 

























Figure 1.4 Cas modulates NF-κB transcriptional activity.  
(A) Cas down-regulates NF-κB transcriptional activity. The NF-κB-
responsive and the Renilla  luciferase reporter vectors, pNF-κB-luc and 
pRL-TK, were co-transfected with FLAG-Cas or HA-p65 or both into 
HEK293 cells. 24 hours after transfection, cells were lysed and 
assayed for luciferase activity as described in the Materials and 
Methods. Relative luciferase activity was scaled with the control (the 
leftmost sample) set at 1 (Error bars denote s.d. *: p<0.05, **: p<0.01, 
as determined by Student’s t-test). The expression levels of Cas and 
NF-κB p65 were evaluated by anti-Cas and anti-p65 immunoblotting.  
Anti-α-tubulin blot provided a loading control (right panel).  
(B) Overexpression of Cas decreases the expression of NF-κB target 
genes. HEK293 cells were transfected with FLAG-Cas or HA-p65 or 
both. 24 hours after transfection, total RNA was extracted and 
subjected to a reverse transcription reaction followed by quantification 
with Real-time PCR using the specific primer sets for TNF-α and IL-8. 
Relative gene expression levels were scaled with the controls (the left 
most sample in each graph) set at 1. Error bars denote s.d. *: p<0.05, 
**: p<0.01. 
 
We next examined the influence of endogenous Cas on NF-κB activation by 
TNF-α, a cytokine that plays a major role in the regulation of inflammatory 
responses by activating NF-κB (Pikarsky et al., 2004).  When we silenced the 
expression of Cas in HEK293 cells, we observed a significant increase in the 
NF-κB activity after TNF-α administration (Figure 1.5A, lanes 3 and 4).  
Consistently, the expressions of NF-κB target genes, TNF-α and IL-8 were 
enhanced in Cas-silenced cells as compared with those in the control HEK293 































Figure 1.5 Cas silencing upregulates NF-κB activation induced by 
TNF-α. 
(A) pNF-κB-luc and pRL-TK cells were co-transfected with Cas-
targeted siRNA (CasKD), or the control siRNA, into HEK293 cells. 24 
hours after transfection, cells were either left untreated or treated with 
TNF-α (10 ng/ml) for additional 8 hours. Cells were then lysed and 
assayed for luciferase activity. Relative luciferase activities were scaled 
with the controls (the leftmost sample in each graph) set at 1. 
Expression level of Cas was evaluated by anti-Cas and anti-α-tubulin 
immunoblotting (right panel in A). Error bars denote s.d. **: p<0.01. 
(B) Silencing of Cas expression enhances the expression of NF-κB 
target genes. HEK293 cells were transfected with control or Cas-
targeted siRNA (CasKD). 24 hours after transfection, cells were either 
left untreated or treated with TNF-α (10 ng/ml) for additional 2 hours. 
Total RNA was extracted and subject to reverse transcription reaction 
followed by quantification with Real-time PCR using the specific primer 
sets for TNF-α andIL-8. Relative gene expression levels were scaled 
with the controls (the leftmost sample in each graph) set at 1. Error 







In line with this, overexpression of Cas resulted in a significant decrease in the 
TNF-α-induced activity of endogenous NF-κB (Figure 1.6, lanes 3 and 4).  











Figure 1.6 Cas expression suppresses NF-κB activation induced 
by TNF-α. 
pNF-κB-luc and pRL-TK cells were co-transfected with FLAG-Cas or 
the control vector into HEK293 cells. 24 hours after transfection, cells 
were either left untreated or treated with TNF-α (10 ng/ml) for additional 
8 hours. Cells were then lysed and assayed for luciferase activity. 
Relative luciferase activities were scaled with the controls (the leftmost 
sample in each graph) set at 1. Expression level of Cas was evaluated 
by anti-Cas, anti-FLAG and anti-α-tubulin immunoblotting (right panel). 
Error bars denote s.d. **: p<0.01. 
 
 
1.3.2 Cas Targets Acetylation of NF-κB p65 Subunit 
We next investigated the molecular mechanism behind the Cas-mediated 
mitigation of the TNF-α-induced NF-κB activation (Figure 1.6).  Since TNF-α 
reportedly activates NF-κB mainly through the classical pathway in which IκB 
kinase β (IKKβ) plays a significant role (Hayden and Ghosh, 2008; Tanaka et 
al., 1999), we tested if Cas modulated IKKβ-induced NF-κB activation by a 





activation by IKKβ SS/EE, a constitutively active form of IKKβ (Figure 1.7A). 
These results indicate that Cas modulates the downstream of the IKK complex 
in the NF-κB activation cascade.  
 It is noteworthy that not only Cas (wild-type) but also Cas15YF, which 
have all YxxP motifs in the CasSD mutated to FxxPs, tempered the IKKβ-
induced NF-κB activation (Figure 1.7A). This suggests that the inhibitory 
effect of Cas is independent of CasSD phosphorylation. 
 
 
Figure 1.7 Cas modulates the downstream of IKK activation. 
(A) Cas down-regulates NF-κB activity induced by constitutively active 
IKKβ. pNF-κB-luc, pRL-TK and HA-IKKβ SS/EE or its control vector 
were co-transfected with FLAG-tagged Cas wild-type (CasWT) or its 
variants into HEK293 cells. 24 hours after transfection, cells were lysed 
and assayed for luciferase activity. Error bars denote s.d. **: p<0.01. 
(B) IKK-induced NF-κB p65 acetylation is attenuated by both Cas and 
its phosphorylation-defective mutant. HA-tagged IKKβ SS/EE or its 
control vector was co-transfected with FLAG-tagged Cas wild-type 
(CasWT) or its phosphorylation-defective mutant (Cas15YF) into 
HEK293 cells. 24 hours after transfection, cells were lysed and 
subjected to SDS-PAGE followed by anti-acetylated p65 (ac-p65), anti-
phosphorylated p65 (p-p65), anti-p65 (total), anti-Cas and anti-GAPDH 
immunoblotting. 
 
Activation of the IKK complex leads to phosphorylation of IκB α and its 






κB that allows it to bind to the κB element and initiate the transcription of 
target genes (Hayden and Ghosh, 2008).  For NF-κB to execute its full 
transcriptional activity, several steps are required in addition to the nuclear 
translocation of NF-κB. A number of regulatory posttranslational 
modifications of p65, including phosphorylation at serine 276 and 536 and 
acetylation at lysine 310, have been reported to alter the NF-κB activity by 
modulating its interaction with IκB or transcriptional coactivators/repressors 
as well as its binding affinity to the κB sites (Chen and Greene, 2004).  We 
therefore tested the p65 phosphorylation at serine 536 and acetylation at lysine 
310, both of which are events downstream of IKK complex activation.  
Whereas p65 phosphorylation induced by IKKβ SS/EE was not affected by the 
expression of Cas or its phosphorylation-defective mutant Cas15YF (Figure 
1.7B), both of these Cas variants significantly mitigated the acetylation of p65 
(Figure 1.7B).  This suggests that Cas targets the p65 acetylation 
independently of tyrosine phosphorylation at its substrate domain. 
 
1.3.3 Cas Is Distributed in the Nucleus 
1.3.3.1 Cas Translocates into the Nucleus upon TNF-α Treatment 
Because p65 is reportedly acetylated at lysine 310 by the acetyltransferase 
p300 exclusively in the nucleus (Chen and Greene, 2004), we speculated that 
Cas might interfere with p65 acetylation in the nucleus.  We therefore 
biochemically analyzed the cytosolic and nuclear fractions to determine the 
subcellular distribution of Cas in the cells treated with TNF-α.  Immunoblot 
analysis revealed that the nuclear distribution of both NF-κB and Cas 





see Figure 1.8A, lanes 2 – 7) although the majority of Cas still remained in the 
cytosol (compare Figure 1.8A lanes 3 and 12).  Consistent with this, the anti-
Cas and anti-p65 immunostaining combined with the nuclear staining (DAPI) 
demonstrated the enhanced nuclear localization of both Cas and NF-κB after 





































Figure 1.8 TNF-α induces nuclear localization of Cas. 
(A) TNF-α induces the nuclear localization of Cas. HEK293 cells were 
treated with TNF-α (10 ng/ml) for indicated periods of time. Equivalent 
portions of the nuclear and cytoplasmic extracts prepared as described 
in the Materials and Methods were subjected to SDS-PAGE followed 
by anti-Cas, anti-acetylated p65, and anti-p65 immunoblotting.  To 
verify the nuclear/cytosolic fractioning and to obtain a loading control 
for the nuclear fraction, anti-Histone H3 and anti-HSP90 
immunoblottings were also conducted. The numbers indicate the fold 
change of band intensity relative to lane 1. 
(B) Detection of TNF-α-induced nuclear localization of Cas by 
immunofluorescence staining. HEK293 cells treated with or without 
TNF-α for 1 hour were fixed and stained with anti-p65 and anti-Cas 
antibodies. DAPI staining was used to visualize the nuclear region. 
Scale bar: 50 µm.  
(C) Quantification of subcellular localization of p65 and Cas upon TNF-
α treatment as in (B).  Intensities of immunofluorescence in (B) were 
quantified and scaled with the samples without TNF-α treatment set at 
1. Error bars denote s.d. **: p<0.01. 
 
1.3.3.2 Cas Accumulates in the Nucleus after Inhibition of Nuclear Export 
Signaling 
To validate and ensure our observation of the TNF-α-induced nuclear 
translocation of Cas and NF-κB (Figure 1.8), we examined whether they 
accumulated in the nuclei of the cells treated with the nuclear export inhibitor 
Leptomycin B.  As shown in Figure 1.9, we found that both NF-κB p65 and 
Cas accumulate in Leptomycin B-treated cells, suggesting that these molecules 
















Figure 1.9 Analysis of Cas distribution after the inhibition of 
nuclear export.   
Anti-Cas and anti-p65 immunofluorescence staining was performed to 
analyze the distribution of Cas and NF-κB in the cells with (right) and 
without (left) Leptomycin B (10 ng/ml) treatment for 6 hours.  To 
visualize the nuclear regions, DAPI staining was also performed. Scale 
bar: 50 µm. 
 
1.3.4 Cas Knockdown Leads to Increased p65 Acetylation upon TNF-α 
Administration 
To examine the physiological relevance of our results from the experiments of 
Cas overexpression in which TNF-α-induced acetylation, but not 
phosphorylation, of p65 was hampered (Figure 1.7B), we examined the effects 
of silencing of endogenous Cas expression on p65 modification upon TNF-α 
treatment.  We found that knockdown of Cas expression using siRNA (see 
Materials and Methods) resulted in an increase in the TNF-α-induced p65 
acetylation, while it did not affect the nuclear distribution and phosphorylation 





negatively regulated the TNF-α-induced NF-κB activation by targeting p65 










Figure 1.10 Silencing of Cas modulates TNF-α-induced NF-κB p65 
acetylation, but not its nuclear translocation or phosphorylation. 
Silencing of Cas expression enhances TNF-α-induced NF-κB p65 
acetylation. HEK293 cells were transfected with Cas-targeted (CasKD 
+) or control siRNA (CasKD -), and treated with TNF-α (10 ng/ml) for 
indicated periods of time. Nuclear and cytosolic fractions were 
analyzed as in Figure 1.8A. The numbers indicate the fold change of 
band intensity relative to lane 1.  
 
1.3.5 Nuclear Distribution Is Required For Cas to Suppress NF-κB 
Activity 
To ensure the Cas-mediated suppression of p65 acetylation in the nucleus, we 
next tested if nuclear distribution of Cas was related to the inhibition of NF-κB 
activity by a luciferase assay.  We constructed a Cas mutant tagged with a 
nuclear exportation signal (NES) whose nuclear distribution was significantly 
impeded (Figure 1.11A).  Unlike Cas wild-type, co-expression of nuclear 
export signal-attached Cas (NES-Cas) did not significantly decrease the NF-



































Figure 1.11 Nuclear distribution is required for Cas to suppress 
NF-κB activity. 
(A) Attachment of NES to Cas impairs its nuclear distribution. HEK293 
cells were transfected with FLAG-tagged Cas, NES-attached Cas or 
their control vector. Nuclear and cytosolic fractions were prepared and 
analyzed.  Note that NES-Cas is poorly detected in the nuclear fraction 
(compare lanes 2 and 3).  
(B and C) NES-attached Cas does not affect NF-κB activation (B) and 
p65 acetylation. pNF-κB-luc and pRL-TK were co-transfected with  
FLAG-tagged Cas, NES-attached Cas or their control vector into 
HEK293 cells, together with p65 or its control vector. The relative NF-
κB activity (B) and p65 acetylation (C) were analyzed as in Figure 1.7A 
and Figure 1.7B, respectively. Error bars denote s.d. **: p<0.01; NS: 
not significant. 
 
1.3.6 Cas and NF-κB p65 Mutually Inhibit Their Binding to the 
Acetyltransferase p300 
1.3.6.1 Cas Targets the Acetylation, But Not Deacetylation, of p65 to 
Suppress NF-κB Activity 
Cas-mediated suppression of NF-κB activity appeared to involve the 
inhibition of p65 acetylation rather than phosphorylation (Figure 1.7B).  We 
then examined how Cas negatively regulated p65 acetylation. Given that p65 
is acetylated by histone acetyltransferase (HAT) and deacetylated by histone 
deacetylase (HDAC) (Chen and Greene, 2004), we asked whether Cas down-
regulated p65 acetylation or up-regulated its deacetylation. As shown in 
Figure 1.12A, treatment of cells with the HDAC inhibitor SAHA enhanced the 
TNF-α-induced p65 acetylation (compare lanes 3, 4 with lanes 5, 6).  However, 
it did not affect the increase in p65 acetylation upon Cas silencing (compare 
lanes 5 and 6).  This suggests that Cas suppresses p65 acetylation by a 
mechanism independent of HDAC-mediated deacetylation. By contrast, TNF-
α-induced p65 acetylation and its enhancement by Cas silencing (Figure 1.12B, 





C646 (Figure 1.12B, lanes 5 and 6).  These results conformed to the 
significant role of p300 in p65 acetylation (Chen and Greene, 2004), leaving 
the possibility that Cas down-regulated p300-mediated acetylation of p65.  
 
 
Figure 1.12 Cas targets acetyltransferase p300, but not HDACs. 
(A) Silencing Cas increases NF-κB p65 acetylation even when HDAC 
is inhibited. HEK293 cells were transfected with Cas-targeted (CasKD 
+) or control siRNA (CasKD -). 12 hours after transfection, HDAC 
inhibitor SAHA (2 μM) or vehicle (DMSO) was administrated. 24 hours 
after transfection (12 hours after SAHA administration), cells, either left 
untreated or treated with TNF-α for 1 hour, were lysed and subjected to 
SDS-PAGE followed by anti-acetylated p65, anti-p65, anti-Cas and 
anti-GAPDH immunoblotting.  
(B) Inhibition of p300 revokes TNF-α-induced NF-κB p65 acetylation 
irrespective of Cas silencing. HEK293 cells were transfected with Cas-
targeted (CasKD +) or control siRNA (CasKD -). 24 hours after 
transfection, cells were pretreated with p300 inhibitor C646 (25 μM) or 
vehicle (DMSO) for 2 h. Cells, either left untreated or treated with TNF-
α for additional 1 hour, were analyzed as in (A). 
 
1.3.6.2 Cas and p65 Mutually Inhibit Their Binding to p300 
Since down-regulation of p300-mediated acetylation appeared to account for 
the Cas-dependent suppression of p65 acetylation (Figures 1.10 and 1.12), we 
examined whether Cas interfered with the physical interaction between p65 
and p300.  To this end, we conducted a co-immunoprecipitation analysis of 
cells with various combinations of exogenous p65, p300, and Cas expressions.  
Consistent with a previous report on the p65-p300 interaction (Gerritsen et al., 






Notably, Cas was also co-immunoprecipitated with p300 (Figure 1.13, lane 2).  
Furthermore, exogenous expression of Cas attenuated the co-
immunoprecipitation of p65 with p300 (Figure 1.13, compare lanes 1 and 3) 
whereas the exogenous expression of p65 hampered Cas-p300 co-
immunoprecipitation (Figure 1.13, compare lanes 2 and 3).  These results 
suggest that Cas and p65 mutually inhibit their binding to p300 probably 
through competition with each other.  
 
            
Figure 1.13 Cas and p65 mutually inhibit their binding to the 
acetyltransferase p300. 
p300-HA and FLAG-p65 were co-transfected with FLAG-Cas or its 
control vector into HEK293 cells. 24 hours after transfection, cells were 
lysed and subjected to anti-HA immunoprecipitation followed by SDS-
PAGE and sebsequent anti-FLAG and anti-HA immunoblotting.  
Equivalent portions from each sample were directly subjected to SDS-
PAGE followed by immunoblotting. 
 
1.3.6.3 Cas Interrupts Complex Formation Of p300 and p65 at NF- κB 
Loci. 
Since the reversible acetylation of p65 subunit regulates its DNA binding 
activity to κB DNA elements (Huang et al., 2010), to further address the 





performed a chromatin immunoprecipitation (CHIP) assay to measure the 
DNA-binding activities of p65 and p300 in the cells with and without 
silencing of Cas expression. We found that the κB element-binding activities 
of both p65 and p300 were enhanced by Cas silencing (Figure 1.14).   Taken 
together, Cas appears to interrupt complex formation by p65 (NF-κB) and 
p300 on the chromatin DNA. 
 
 
Figure 1.14 Cas interrupts complex formation by p300 and NF-κB 
p65 on κB sites. 
Cas silencing enhances the DNA-binding activities of p65 and p300. 
HEK293 cells were transfected with Cas-targeted (CasKD) or control 
siRNA (Control). 24 hours after transfection, cells were treated with 
TNF-α (10 ng/ml) for 1 hour. CHIP assay was then conducted using 
anti-p65 (left panel) or anti-p300 (right panel) antibody as described in 
the Materials and Methods.  Relative DNA-binding activity was scaled 
with the control sample set at 1. Error bars denote s.d. *: p<0.05, **: 
p<0.01. 
 
1.3.7 The Amino Acids 672-738 of Cas Are Critical for Its Inhibitory 
Effect on NF-κB Activity 
To determine the region of Cas responsible for inhibiting NF-κB activity, we 
tested various truncation mutants of Cas as presented in Figure 1.15A. Similar 
to full-length Cas (Cas1-874), Cas1-738, Cas458-874, Cas639-874 and 





as the acetylation of NF-κB p65 subunit induced by TNF-α treatment, while 
Cas1-457, Cas1-638, Cas1-671 and Cas739-874 did not demonstrate 










Figure 1.15 Functional domain mapping of Cas in terms of 
inhibitory effects on NF-κB activity. 
(A) Schematic presentation the truncation mutants of Cas used in this 
study. (SH3: Src homology 3; SD: substrate domain; SRR: serine rich 
region; SBD: Src-binding domain) 
(B) Cas variants including a.a. 672-738 suppress NF-κB transcriptional 
activity. NF-κB-luc and pRL-TK were co-transfected with FLAG-tagged 
Cas or its truncated mutants. 24 hours after transfection, cells were 
either left untreated or treated with TNF-α (10 ng/ml) for additional 8 
hour, and then lysed.  Relative luciferase activity was analyzed as in 
Figure 1.2A. Error bars denote s.d. **: p<0.01. 
(C) Cas variants including a.a. 672-738 suppress TNF-α-induced NF-
κB p65 acetylation. HEK293 cells were transfected with FLAG-tagged 
Cas or its truncation mutants. 24 hours after transfection, cells were 
either left untreated or treated with TNF-α (10 ng/ml) for additional 1 
hour. Cells were then lysed and subjected to SDS-PAGE followed by 
anti-acetylated p65, anti-p65, anti-FLAG and anti-GAPDH 
immunoblotting.  The bands at ~90 kDa indicated by an asterisk in the 
anti-FLAG blot derived from non-specific binding of the anti-FLAG 
antibody used.  
 
In addition, we found that p300 co-immunoprecipitated with Cas1-738, 
Cas458-874, Cas639-874 or Cas672-874, but not with Cas1-457, Cas1-638, 
Cas1-671 or Cas739-874 (Figure 1.16A). Furthermore, Cas672-874 and p65 
appeared to mutually inhibit their association with p300 (Figure 1.16B). 
Collectively, these results suggest that amino acid 672-738 of Cas is 
responsible for the interference with p65 acetylation responsible for the 









Figure 1.16 A C-terminal region of Cas (Cas672-738) is 
responsible for the interaction with p300. 
(A) Cas variants including amino acids 672-738 co-immunoprecipitate 
with p300. HA-tagged p300 was co-transfected with FLAG-tagged Cas 
or its truncation mutants into HEK293 cells. 24 hours after transfection, 
cells were lysed and subjected to anti-HA immunoprecipitation followed 
by SDS-PAGE and anti-FLAG or anti-HA immunoblotting. As in Figure 
1.15C, non-specific binding of anti-FLAG antibody was observed at ~90 
kDa (see asterisks in anti-FLAG blots). 
(B) Cas672-874 and NF-κB p65 mutually inhibit their association with 
p300. HA-tagged p300 was co-transfected with FLAG-tagged p65 or 
Cas or both into HEK 293 cells. 24 hours after transfection, cells were 
lysed and subjected to anti-HA immunoprecipitation followed by SDS-
PAGE and subsequent anti-FLAG and anti-HA immunoblotting. 
Equivalent portions from each sample were directly subjected to SDS-








According to previous reports, it appears possible that phosphorylated Cas 
induces NF-κB activation through the small GTPase Rac. In line with this, the 
overexpression of Cas, which activates the signaling related to phosphorylated 
Cas (Sawada et al., 2006), resulted in a mild increase in the activity of 
endogenous NF-κB in unstimulated HEK293 cells (compare column 1 and 2 
of Figure 1.6B). However, Cas demonstrates an inhibitory effect on TNF-α-
induced NF-κB activation (compare column 3 and 4 of Figure 1.6B), implying 
a novel role of Cas in regulating NF-κB activity. This notion is further 
supported by the finding that the expression of NF-κB target genes induced by 
TNF-α, such as IL-8 and TNF-α, is significantly enhanced by silencing Cas 
(Figure 1.6C). In addition, the phosphorylation-defective Cas mutant 
(Cas15YF) suppressed NF-κB activity as Cas (wild-type) did, indicating that 
phosphorylation is not required for Cas to inhibit NF-κB activation.  
Although previous studies on Cas have mainly focused on its role as a 
tyrosine phosphorylated protein in focal adhesions, the majority (>90%) of 
Cas molecules are unphosphorylated and distributed in the cytosol 
(Machiyama et al., 2014). It remains unclear whether cytosolic Cas contributes 
to the regulation of cell functions. We observed that TNF-α induced nuclear 
translocation of Cas into the nucleus, where Cas functioned to alleviate TNF-
α-induced NF-κB activation. The inhibitory effect of Cas on NF-κB activation 
requires its nuclear distribution, because the expression of NES-attached Cas 
does not suppress NF-κB activity. Cas15YF is also distributed in the nucleus, 





independent process. Consistently we observed that Cas15YF suppressed NF-
κB activity. 
From the accumulation in the nuclei of Leptomycin B-treated cells 
(Figure 1.9), Cas appears to shuttle between the cytosol and the nucleus. 
However, the mechanism that mediates nuclear translocation of Cas remains 
unknown. Cas has been reported to bind to several NLS (nuclear localization 
signal)-containing proteins such as Ajuba, zyxin and Trip6, which have been 
shown to localize in the nucleus (Lai et al., 2005; Pratt et al., 2005; Yi et al., 
2002). It is possible that these binding partners facilitate the nuclear 
translocation of Cas. 
Cas responds to TNF-α stimulation and translocates into the nucleus to 
down-regulate p65 acetylation. We speculate that Cas alleviates TNF-α-
induced NF-κB activation to protect cells from detrimental effects resulting 
from NF-κB hyperactivation. In other words, Cas provides a protective 
mechanism to counteract NF-κB activation upon TNF-α treatment. In the 
absence of Cas, cells may suffer from hyperactivation of NF-κB, which may 
result in aberrant expressions of NF-κB target genes, leading to dysfunctions 
of cells and tissues. 
IKK activation is a critical step in the TNF-α-induced NF-κB signaling 
(Hayden and Ghosh, 2008). We demonstrate that Cas down-regulates NF-κB 
activity enhanced by the constitutively active IKK (IKKβ SS/EE), suggesting 
that Cas targets the downstream of IKK activation. By analyzing nuclear 
distribution as well as posttranslational modifications of NF-κB p65, we have 
identified acetylation of p65 as the target of Cas. By selectively inhibiting 





that Cas-mediated suppression of NF-κB activity relies on the inhibition of 
acetylation, but not enhancement of deacetylation, of p65. Our co-
immunoprecipitation and CHIP experiments further support the notion that 
Cas targets p300 to modulate NF-κB activity. 
Our present analysis is limited to the TNF-α-induced NF-κB activation.  
However, p300/CBP and p65, both of which are the key molecules in Cas-
mediated NF-κB regulation, have been shown to relate to severe 
developmental defects and pathological conditions (Partanen et al., 1999; 
Shikama et al., 2003; Yao et al., 1998).  Therefore, Cas-dependent alleviation 
of NF-κB activity may have broader impact on in vivo events, either 
physiological or pathological. 
While the amino acids 672-738 of Cas were found to be critical for 
binding to p300 and inhibition of NF-κB, manifest functions or interacting 
proteins for this specific region of Cas have not been reported to date. Through 
the sequence comparison with another Cas family member NEDD9, also 
known as CasL, we have found that this region is highly conserved between 
the two proteins, raising a possibility that NEDD9 may modulate NF-κB 
activity as well. It has been shown that a carboxy-terminal 31-kD cleavage 
fragment of Cas is generated by a caspase and translocated to the nucleus 
together with E2A protein in apoptotic cells (Kim et al., 2004). However, we 
did not observe any distinct apoptosis or cell death upon exogenous Cas 
expression, which suppressed NF-κB activity. In addition, NES-Cas, in which 
NES was attached to the amino-terminus and the carboxy-terminus was not 
modulated, did not exhibit an inhibitory effect on NF-κB activity and p65 





fragment of Cas is responsible for inhibiting NF-κB activity. Our findings also 
suggest that the inhibitory effect of Cas on NF-κB activity is exerted in the 
nucleus. 
Previous study has shown that physical extension of Cas substrate 
domain (CasSD) by an externally applied force enhances its susceptibility to 
Src family kinases, resulting in its increased phosphorylation that facilitates 
the downstream signaling events (Sawada et al., 2006). However, in the case 
of Cas-mediated NF-κB inhibition, CasSD phosphorylation is not required. 
Given that unphosphorylated Cas molecules are distributed in the cytosol 
(Machiyama et al., 2014) and that responses to mechanical cues may differ 
depending on subcellular locations, it is possible that the nuclear translocation 
of Cas is also mechanically regulated. 
It was reported that Cas influenced actin remodeling and concomitant 
muscle-specific gene expression, thereby regulating myogenic differentiation. 
In C2C12 myoblasts, silencing of Cas expression by RNA interference 
impaired F-actin formation the induction of myogenic differentiation. 
Consequently, formation of multinucleated myotubes was abolished 
(Kawauchi et al., 2012). Chronic low-grade inflammation, in which NF-κB 
has been reported to play a significant role (Adler et al., 2008; Salminen and 
Kaarniranta, 2009), has been recognized as an important causative factor for 
the age-related progressive decline of muscle mass and strength (sarcopenia) 
(Beyer et al., 2012). In this study, we found that Cas had a negative impact on 
NF-κB p65 acetylation despite no significant alteration of p65 phosphorylation, 
conforming to the functional crosstalk between Cas and NF-κB, the central 





nucleus and inhibit acetylation of p65 by interfering with its physical 
association with p300, resulting in impaired nuclear DNA-binding activity of 
classical NF-κB. Considering that aberrant NF-κB activation is supposed to 
accompany human aging (Salminen and Kaarniranta, 2009), dysfunction of 
Cas-mediated signaling pathways may result in accelerated aging processes in 
a living body. 
 Collectively, we have found a novel role for the mechanosensing 
protein Cas, which is the alleviation of stress-induced NF-κB activation 
(Figure 1.17). While further study on the mechanism underlying the inhibitory 
effect of Cas on NF-κB activity is required to translate this to clinical 
applications, the physiological relevance of the Cas-NF-κB interplay is 

















Figure 1.17 Model of Cas-mediated alleviation of NF-κB activation. 
Cas translocates into the nucleus and suppresses acetylation of NF-κB 
p65 subunit by interfering with the association between p65 and its 






Part II Physiological Relevance and Implication of the Cas-NF-κB 
Interplay in Bone Metabolism 
 
2.1 Introduction 
2.1.1 Skeleton and Osteoporosis 
Bone is a highly specialized supporting framework of the body, characterized 
by its rigidity, hardness, and power of regeneration and repair. It mechanically 
supports the muscular activity, protects the vital organs, provides an 
environment for marrow (both blood forming and fat storage), serves as a 
reservoir of calcium as well as growth factors and cytokines, and also takes 
part in the maintenance of the acid–base balance. 
 It is known that bone has the ability to adapt its outer shape and inner 
microstructure to a changing mechanical environment. The mechanism of such 
bone functional adaptation has long been of interest, and models for bone 
remodeling based on experimental studies have been proposed and testified 
(Price et al., 2011; Sugiyama et al., 2010). 
Bone constantly undergoes modeling (reshaping) during life to adapt to 
changing biomechanical forces, as well as remodeling to remove old, 
microdamaged bone and replace it with new, mechanically stronger bone to 
help preserve bone strength.  In childhood and during the teens, bone 
formation is slightly ahead as compared to resorption. Peak bone mass is 
typically reached in the twenties, and from then onwards, bone resorption has 
the upper hand over formation. There are two reasons for the constant 
remodeling process. First, it allows bones to adapt to changes in mechanical 





caused by recurrent microtraumas. The disruption of this constant remodeling 
process gives rise to osteoporosis, which leads to the vulnerability of bone to 
fracture, raising a worldwide health concern and resulting in an enormous 
economic burden on healthcare systems (Rachner et al., 2011). 
 
2.1.2 Osteocytes and Bone Metabolism 
2.1.2.1 Bone Cells 
Osteoblasts and osteoclasts are known as the two types of cells directly 
responsible for bone remodeling (Raggatt and Partridge, 2010). Osteoblasts 
derive from osteoprogenitor cells in bone marrow stroma and are responsible 
for producing organic part of bone matrix. Osteoblasts are mononucleated, and 
their cellular activity varies at different stage of maturity depending on their 
morphology. Ultimately, some osteoblasts are embedded in the bone matrix, 
differentiated into osteocytes (Long, 2012). Osteoclasts are multinucleated 
cells that originate from hematopoietic progenitor cells in the bone marrow, 
branching from mononuclear precursor cells of the monocyte-macrophage 
lineage. Osteoclasts are activated to break down bone tissue after being 
recruited to the microfracture sites (Edwards and Mundy, 2011). 
During a typical bone remodeling process, osteoclastic bone resorption 
is followed by the recruitment of osteoblasts. At the first place, osteoclasts are 
targeted to the damaged sites of skeleton, triggering bone resorption for the 
purpose of removing bone with compromised mechanical integrity. 
Subsequently, osteoblasts actively secrete extracellular matrix and mineralize 
it to generate bone with mechanical competence. Notably, bone formation and 





(Eriksen, 2010). For example, parathyroid hormone (PTH) is reported to 
induce osteoclastic bone resorption, although osteoclasts have no receptor for 
PTH (Xiong et al., 2011). Interestingly, osteoblasts have receptors for PTH, 
and ablation of osteoblasts diminishes the PTH-induced osteoclastic bone 
resorption, suggesting an interplay between osteoblasts and osteoclasts (Jilka 
et al., 2010). 
Osteocytes, composing more than 90% of bone cell population, 
represent terminally differentiated osteoblasts and encase themselves in 
mineralized matrix (Figure 2.1). Individual osteocyte resides in caves called 
lacunae and forming a complex network connected by long cellular processes. 
Through such an extensive neuron-like network, osteocytes, typically star-
shaped, establish intercellular communications with each other as well as  with 
osteoblasts and lining cells on the bone surface with their dendritic processes 
(Schaffler et al., 2014).  
 
         
Figure 2.1 Morphology of osteocytes. 
(A) Scanning electron microscopy micrograph (570x) of a cross section 
of bone. Arrows point to osteocytes embedded in bone. 
(B) Transmission electron microscopy micrographs (14,000x) of 
osteocyte inside the cortex. The pictures are adapted from (Rubinacci 







The presence of empty lacunae in aged bone suggests that osteocytes 
may undergo apoptosis, probably caused by disruption of their intercellular 
gap junctions or cell-matrix interactions. Osteocyte apoptosis in response to 
estrogen deficiency or glucocorticoid treatment is harmful to bone structure 
(Jilka et al., 2013). 
 
2.1.2.2 Receptor Activator of Nuclear Factor κB Ligand (RANKL) and 
Sclerostin (Sost) 
Osteocytes control both osteoclastic bone resorption and osteoblastic bone 
formation through secreting paracrine and systemic regulators, affecting the 
activity of bone remodeling cells and the rate at which bones are destroyed, 
made and changed in shape (Nakashima et al., 2011; Schaffler et al., 2014). 
As shown in the Figure 2.2, in the context of osteoclastic bone 
resorption, the differentiation of osteoclast precursor cells into fully functional 
osteoclasts requires activation of the cellular surface receptor RANK (receptor 
activator of nuclear factor κB) by RANK ligand (RANKL) binding. Recent 
studies have revealed that osteocytes, but not osteoblasts, support osteoclast 
formation by expressing RANKL and presenting an osteoclastogenic 
microenvironment (Nakashima et al., 2011). In addition, osteocytes also 
regulate bone resorption through osteoprotegerin (OPG), which is a decoy 
receptor that binds to RANKL and inhibits its binding with RANK (Weinstein 
et al., 2011). As for osteoblastic bone formation, sclerostin, expressed by 
osteocytes, reportedly inhibits Wnt signaling in osteoblasts and impedes bone 





actions, such as stimulation of RANKL expression by osteocytes (Poole et al., 
2005). 
 
Figure 2.2 Schematic diagram depicting the mechanisms by which 
osteocytes control bone resorption and bone formation.  
OCs: osteoclasts; OBs: osteoblasts; pOC: precursors of osteoclasts; 
pOB: precursors of osteoblasts. The picture is adapted from (Xiong and 
O'Brien, 2012). 
 
2.1.3 Mitochondrial Function and Reactive Oxidative Stress (ROS) 
Mitochondria are the intracellular organelles responsible for biological 
oxidation in mammalian cells. They contain hundreds of proteins and 2–10 
copies of mitochondrial DNA (mtDNA) in the matrix enclosed by a double-
membrane barrier. In addition to its major function, which is the energy 
production, mitochondria are the main intracellular source and also the 
immediate target of ROS, which are continually generated as byproducts of 
aerobic metabolism in mammalian cells (Marchi et al., 2012).  
To date, numerous studies have shown the positive correlation between 
oxidative stress and osteoporotic status (Wauquier et al., 2009). For instance, 





been shown to be associated with higher plasma lipid oxidation (Sendur et al., 
2009). In addition, ovariectomy induces oxidative stress in rat femurs together 
with a decreased activity of antioxidant systems (Onal et al., 2012). Given the 
potentially significant implication of mitochondrial dysfunction in the 
pathogenesis of numerous diseases and in the process of aging, understanding 
the molecular mechanisms regulating mitochondrial function/biogenesis may 
provide important novel therapeutic targets. 
 
2.1.4 NF-κB in Bone Metabolism 
The role of NF-κB in regulating osteoclasts and osteoblasts has been 
extensively studied. Activation of NF-κB signaling, such as seen in 
inflammatory arthritis and osteoporosis, increases osteoclastic bone resorption 
and may inhibit osteoblastic bone formation, making the upstream kinase 
IKKβ an attractive therapeutic target (Chang et al., 2009). By contrast, there 
are relatively few studies on intracellular signaling in osteocytes due to a 
relative paucity of in vitro model systems. To our knowledge there are only 
few reports on NF-κB activation specifically in osteocytes. Given that 
osteocytes and osteoblasts do not always respond in the same way to identical 
stimuli, potential roles of NF-κB in osteocytes will have to be determined 
experimentally. 
 
2.1.5 Mechanical Regulation of Bone Turnover 
The bones of the living body are subjected to mechanical strains in the daily 
life. The orientation and magnitude may vary in these strains incurred 





Generally, the normal osteoclastic and osteoblastic activity is able to repair the 
damage and maintain bone homeostasis. However, if excessive exercise, 
which exerts repeated and prolonged loading on bone, causes the damage 
accumulated faster that it can be repaired, it may result in fracture. On the 
other hand, mechanical loading is critical to maintain bone mass. On the other 
hand, mechanical unloading, which can result from reduced physical activity, 
immobilization on bed, and motor paralyses, causes bone loss, leading to 
disuse osteoporosis (Bikle et al., 2003). Furthermore, astronauts who lead a 
daily life under microgravity conditions suffer from bone loss, which 
represents the most significant hindrance for long-term space flying (Sibonga 
et al., 2007). To sum up, mechanical regulation of bone turnover is evident 
although the underlying mechanism remains largely elusive. 
 
2.1.6 Osteocytes as the Mechanosensory Cells in Bone 
The roles of osteocytes in bone metabolism are revealed by the defective 
response of bone to mechanical unloading after the ablation of osteocytes. 
Their regulatory role in bone metabolism is also highlighted by the fact that 
osteocytes secrete paracrine and systemic regulators that affect bone formation 
and resorption formation mediated by osteoblasts and osteoclasts, respectively 
(Schaffler et al., 2014). Interestingly, the ‘‘osteocyte-less’’ mice are resistant 
to unloading-induced bone loss, providing evidence for the role of osteocytes 
in mechanotransduction (Tatsumi et al., 2007). 
Although it has been postulated that osteocytes play a major role in 
sensing mechanical cues and providing signals to which bone tissues can 





regulatory functions on the effector cells, i.e. osteoblasts and osteoclasts, 
remain largely elusive. 
 
2.1.7 Mechanical Stress Exerted on Osteocytes 
In the process of remodelling through which bone functionally adapts to 
mechanical loads, osteocytes in the lacuno-canalicular system are believed to 
play important roles as a mechanosensory system (Chen et al., 2010b). Under 
dynamic mechanical loads, bone matrix deformation generates an interstitial 
fluid flow in the lacuno-canalicular system; this flow induces a shear stress on 
the osteocytic process membrane that is known to stimulate the osteocytes 
(Figure 2.3). In this sense, the osteocytes behave as mechanosensor cells and 
deliver mechanical information to neighboring cells through the intercellular 










Figure 2.3 A model for the mechanical load-induced shear stress 
on osteocytes.  
Mechanical loads on bone induce fluid flow in the canalicular space 
where osteocytes’ processes reside, eliciting biochemical responses in 
osteocytes. The picture is adapted from (Chen et al., 2010b). 
 
2.1.8 Possible Role of Cas-NF-κB Interplay in Osteocytes in the 
Regulation of Bone Metabolism 
As mentioned in 2.1.4, NF-κB has been reported to be involved in bone 
metabolism (Chang et al., 2009).  Since the expression of Cas is ubiquitous in 
solid organs, we postulated that the Cas-NF-κB interplay plays an important 
role in the function of bone cells. Expecting an implication of Cas in 
physiological mechanosensing, we hypothesized that the Cas-NF-κB interplay 
might regulate the function of osteocytes, the mechanosensory cells in bone. 
 
2.1.9 Strategy to Test the Role of Cas and NF-κB in Osteocytes’ Function 
To investigate the role of Cas in bone metabolism, we first generated 
osteocyte-specific Cas knockout (KO) mice.  To explore the molecular 
mechanism of the signaling that involves the Cas-NF-κB interplay in 
osteocytes, we utilized MLO-Y4 (murine long bone osteocyte Y4) cells for in 
vitro studies. 
The shear stress exerted on osteocytes during daily activities has been 
estimated to range from 0.8 – 3 Pa (Lu et al., 2012). In our study, we applied 
an oscillatory shear stress averaged at 1 Pa to MLO-Y4 osteocytes, and 
investigated the role of Cas-NF-κB interplay in osteocytes under the 






2.2 Materials and Methods 
2.2.1 Animals 
Casflox/flox and Tfamflox/floxmice of C57BL/6 background were mated to Dmp1-
Cre transgenic mice, in which the Cre recombinase gene specifically 
expressed in osteocytes (Lu et al., 2007). Dmp1- Cre+/–, Casflox/flox (Cas cKO) 
and Dmp1-Cre-/- Casflox/flox (normal littermates) mice were generated by mating 
Dmp1-Cre–/–, Casflox/flox male mice with Dmp1-Cre+/–, Casflox/+ female mice. 
Dmp1-Cre+/–, Tfamfoxl/flox (Tfam cKO) and Dmp1-Cre–/–, Tfamfoxl/flox (normal 
littermates) mice were also generated by mating Dmp1-Cre–/–, Tfamfoxl/flox male 
mice with Dmp1-Cre+/–, Tfamflox/+ female mice. All animals were housed under 
specific pathogen-free conditions and treated with humane care under 
approval from the Animal Care and Use Committee of Tokyo Metropolitan 
Institute of Gerontology. 
2.2.2 Mitochondrial Fractionation and ATP Assay 
Mitochondria-enriched fractions were isolated using a Mitochondria Isolation 
Kit for Cultured Cells (Thermo Scientific) according to the manufacturer’s 
instructions. The protein content of the mitochondrial fractions was expressed 
as a percentage of the total protein of the corresponding whole-cell extract. 
Intracellular ATP levels were assayed using ATPlite (Perkin Elmer) according 
to the manufacturer’s instructions. Luminescence was measured using an 
EnVision multilabel reader (Perkin Elmer). The standard curve for ATP was 
made with a series of dilutions. ATP concentrations were normalized for 
protein concentration. 





mtDNA copy number per nuclear genome in MEFs and MLO-Y4 cells was 
quantitated as previously described (Chen et al., 2010a). Total DNA 
purification was performed using the DNeasy kit (Qiagen). The abundance of 
nuclear and mitochondrial DNA was quantified by real-time PCR under 
standard conditions using QuantiTect SYBR Green PCR Kit (Qiagen). The 
ratios between mtDNA and nuclear DNA concentrations were graphed. Primer 
sequences used are described in Supplementary Information.  
2.2.4 Analysis of Bone Phenotype 
Radiography was performed using a high-resolution soft X-ray system 
(SOFTEX, Ebina, Japan). Microcomputed tomography (μCT) scanning was 
performed using a ScanXmate-L090 Scanner (Comscan Techno, Yokohama, 
Japan). Three-dimensional microstructural image data were reconstructed, and 
structural indices were calculated using TRI/3D-BON software (RATOC 
Systems, Osaka, Japan).  
2.2.5 Cell Culture 
MLO-Y4 cells were routinely maintained in αMEM (Minimum Essential 
Medium Alpha Modification, Wako) with 2.5% FBS (fetal bovine serum, Life 
Technologies), 2.5% iron-supplemented calf serum (iCS; HyClone 
Laboratories, Logan, UT, USA), and penicillin/streptomycin (100 IU/ml and 
100 μg/ml) at 37°C. Cas-deficient mouse embryonic fibroblasts (MEFs) and 
human embryonic kidney (HEK) 293 cells were cultured in DMEM 
(Dulbecco’s modified Eagle’s medium, Nissui Pharmaceutical) supplemented 






Polyclonal anti-Cas antibody (αCas3) was described previously (Sawada et al., 
2006). Monoclonal anti-Cas antibody was purchased from BD Biosciences 
(San Diego, CA, USA). Monoclonal anti-α-tubulin, and anti-Tfam antibodies 
were purchased from Invitrogen (Carlsbad, CA, USA), and Aviva Systems 
Biology (San Diego, CA, USA), respectively. Anti-Cre antibodies were from 
Covance (Denver, PA, USA). Monoclonal anti-p65, anti-GAPDH, and anti-
p300 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Polyclonal anti-phospho-p65 (serine 536), monoclonal anti-histone H3, 
polyclonal anti-acetylated-p65 (lysine 310), and anti-β-actin antibodies were 
purchased from Cell Signaling Technology (Beverly, MA, USA). 
2.2.7 Primer Sequences Used for Real-time PCR Analysis 
Primer sequences used were as follows. Mouse GAPDH: 5′-
GGATGCAGGGATGATGTTCT-3′ and 5′-
AACTTTGCCATTGTGGAAGG-3′, mouse Sost: 5′-
TCCTGAGAAGAACCAGACCA-3′ and 5′-
GCAGCTGTACTCGGACACATC-3′, mouse OPG: 5′-
GTTTCCCGAGGACCACAAT-3′ and 5′-
CCATTCAATGATGTCCAGGAG-3′, mouse RANKL: 5′-
CAAGCTCCGAGCTGGTGAAG-3′ and 5′-
CCTGAACTTTGAAAGCCCCA-3′, mouse mtDNA: 5′-
CCTATCACCCTTGCCATCAT-3′ and 5′-GAGGCTGTTGCTTGTGTGAC-
3′, mouse nuclear DNA (platelet endothelial cell adhesion molecule 
(PECAM)): 5′-ATGGAAAGCCTGCCATCATG-3′ and 5′-
TCCTTGTTGTTCAGCATCAC-3′. The primers used for CHIP assay were as 





GTGCCTCTTTCACTCCCACAT-3′(Liu et al., 2005). Mouse TNF-α:5′- 
TGTACCGCAGTCAAGATATG-3′ and 5′-TGCCTGTGTCTATTTCCTTT-
3′(Pakala et al., 2010). 
2.2.8 RNA Interference and Retroviral Gene Transfer 
The retroviral vectors pSuper-sh-Cas puro and –sh-p65 puro were cloned with 
the mouse Cas target sequence 5′-GCATGACATCTACCAAGTT-3′ and the 
mouse p65 target sequence 5′-GAAGAAGAGTCCTTTCAAT-3′, respectively, 
into a pSuper puro vector (Oligoengine, Seattle, WA). For double gene 
silencing of Cas and p65, the retroviral vector pSuper-sh-p65 hygro, in which 
the mouse p65 target sequence was cloned into a pSuper hygro vector, was 
used together with pSuper-sh-Cas puro (Kawauchi et al., 2012).  
                 The plasmid harboring the retroviral construct was transiently 
transfected into the packaging cell line. Supernatants containing retroviral 
particles were collected 24–48 hours after transfection and were used 
immediately to infect cell cultures. Subconfluent MLO-Y4 osteocytic cells 
were exposed to viral supernatants in the presence of 6 μg/ml polybrene for 24 
hours and then incubated in fresh culture medium for 2 days. Infected cells 
were selected by culturing them in the presence of puromycin (5 μg/ml) for at 
least 4 days. For double gene silencing, doubly-infected cells were selected by 
culturing them in the presence of hygromycin (400 μg/ml) and puromycin. 
2.2.9 Analysis of Protein Expression and Modification in Tissues and Cells 
Muscle, connective tissue, and periosteum were removed from femurs and 
tibiae to separate osteocytes from whole bone, and the bones were cut at the 
metaphyses. Hematopoietic cells and osteoblastic cells were removed from the 





interdental brush (0.2 mm in diameter). The remaining bone was used as a 
source of osteocyte-enriched cells. The osteocyte-rich bones were frozen in 
liquid nitrogen and ground into a powder using a tissue pulverizer. The 
powdered bone was then transferred for extraction of RNA, DNA, and protein. 
MLO-Y4 osteocyte-like cells, MEFs, HEK293 cells, and osteocyte fractions 
were harvested and cell lysates were subjected to immunoblot analysis.  
2.2.10 Shear Stress Experiment  
MLO-Y4 osteocytes were cultured in a 60-mm plastic dish (Iwaki) pre-coated 
with collagen. The experiments were conducted 1 day after the cells were 
seeded. To expose MLO-Y4 cells to shear stress, a parallel plate flow-chamber 
and roller pump (HV-07523-80, Master Flex) were used. The flow-chamber 
was composed of a cell culture dish, a polycarbonate I/O unit, and a silicone 
gasket. The systems were put in the CO2 incubator to maintain pH and 
temperature. The flow channel with a length of 35 mm, a width of 28 mm and 
a height of 0.3 mm was used for generating shear stress of 1.0 Pa. MLO-Y4 
cells were exposed to a shear stress of 2.0 Pa and a frequency of 1Hz. 
2.2.11 Statistics 
Statistical analyses were performed using a 2-tailed unpaired Student’s t test 
or ANOVA analysis, and each series of experiments was repeated at least 3 







2.3.1 The Analysis of Osteocyte-specific Cas Knockout Mice Phenotype 
2.3.1.1 Cas cKO Develops Bone Loss after Birth 
Following our strategy stated in Section 2.1.9, we generated osteocyte-specific 
Cas conditional knockout (cKO) mice by mating Casflox/flox mice with Dentin 
matrix protein 1 (Dmp1)-Cre transgenic mice, in which the Cre recombinase 
gene was specifically expressed in osteocytes. The resulting Dmp1-Cre+/–, 
Casflox/floxmice (referred to herein as Cas cKO mice) were born alive at 
predicted Mendelian frequencies. Cas expression was markedly reduced in 
osteocytes from Cas cKO mice (Figure 2.4A), while it was comparable in 
osteoclasts, osteoblasts, and other tissues of Cas cKO mice and control Dmp1-
Cre–/–, Casflox/floxlittermates. Although the bone phenotype was not evident in 
Cas cKO mice at birth and they grew normally with no apparent 
morphological abnormalities (Figure2.4B and 2.4C), 10-week-old Cas cKO 
mice exhibited a remarkable decrease in trabecular bone volume, as 
























     





Figure 2.4 Generation and skeletal analysis of Cas cKO mice. 
(A) Expression of Cas, actin, and Cre proteins in the osteocyte 
fractions derived from Cas cKO mice and their normal 
Casflox/flox littermates. Cas expression was markedly reduced in the 
osteocyte fractions derived from Cas cKO mice.  
(B) µCT analysis of femurs of Cas cKO and their normal 
Casflox/flox newborn mice (postnatal day 1). Left: whole skeleton, right: 
axial view of the metaphyseal femur. Scale bars, 5 mm (left), 250 µm 
(right).  
(C) Body weight of Cas cKO mice and their normal Casflox/flox littermates 
at 1 day or 10 weeks of age (n = 5 for each genotype). Error bars 
denote s.d. NS, not significant. 
(D and E) Representative radiography images of the femur (D) and 
distal femur µCT (E) of male Cas cKO mice and their normal 
Casflox/flox littermates at 10 weeks of age. Arrows in (D) point to 
apparent differences in bone density observed between them. Scale 
bar: 1000 µm.  
 
2.3.1.2 The Decreased Bone Mass Observed in Cas cKO Mice Was Caused 
by Increased Bone Resorption 
Histomorphometric analysis of 10-week-old Cas cKO mice revealed a 
significant increase in the eroded surface/bone surface ratio, osteoclast 
surface, and osteoclast number (Figure 2.5A). However, the bone formation 
parameters were equivalent with those in normal Casflox/flox littermates (Figure 
2.5B). Collectively, these findings suggest that the bone loss in Cas cKO mice 
was caused by increased bone resorption, rather than by decreased bone 
formation, and that osteoclasts are the primary effector cells controlled by the 










Figure 2.5 The decreased bone mass observed in Cas cKO mice is 
caused by increased bone resorption. 
(A) Bone volume and parameters for osteoclastic bone resorption in 
the bone morphometric analysis of male Cas cKO mice and their 
normal Casflox/flox littermates at 10 weeks of age (n = 5 for each 
genotype). Error bars denote s.d. *: p<0.05 versus normal Casflox/flox 
littermates. 
(B) Parameters for osteoblastic bone formation in the bone 
morphometric analysis of male Cas cKO mice and their normal 
Casflox/flox littermates at 10 weeks of age (n = 5 for each genotype). 
Error bars denote s.d. NS: not significant. 
 
2.3.2 Molecular Mechanism Behind the Phenotype of Osteocyte-Specific 
Cas Knockout Mice: Involvement of Increased RANKL Expression 
Negative regulation of osteoblastic activity by osteocytes has recently been 
documented (Fujita et al., 2014). Sclerostin, which is secreted by osteocytes, 
inhibits osteoblast proliferation and differentiation while promoting osteoblast 
apoptosis. The level of sclerostin expression in bones of Cas cKO mice 
remained unchanged when compared with those of Casflox/flox mice (Figure 
2.6A), which is consistent with our findings that parameters of osteoblastic 
bone formation in Cas cKO mice are comparable with those in Casflox/flox mice 
(Figure 2.5B). These results suggest that the decreased bone mass observed in 
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Cas cKO mice does not involve a sclerostin-mediated suppression of 
osteoblastic function, that is, bone formation.  
 
 
Figure 2.6 Cas deficiency leads to increased RANKL expression in 
osteocytes. 
(A) The levels of mRNA expression of sclerostin, OPG, and RANKL in 
the osteocyte fractions derived from male Cas cKO mice and their 
normal Casflox/flox littermates. Error bars denote s.d. *: p<0.05; NS: not 
significant. 
(B) The levels of mRNA expression of sclerostin, OPG, and RANKL 
genes in MLO-Y4 cells. Cas silencing up-regulated RANKL expression 
in MLO-Y4 cells. Error bars denote s.d. *: p<0.05; NS: not significant. 
 
The effector cells of bone resorption are osteoclasts, the differentiation of 
which is reportedly induced by direct cell-cell contact of pre-
osteoblastic/stromal cells with monocyte/macrophage osteoclast precursors 
(Boyle et al., 2003). Two key molecules have been found to mediate this 
interaction: receptor activator of NF-κB ligand (RANKL) and osteoprotegerin 
(OPG). RANKL stimulates osteoclast precursors to commit to the osteoclastic 
phenotype by binding to its receptor (RANK) on the surface of osteoclast 
precursors. OPG is a decoy receptor that interacts with RANKL and inhibits 
its binding with RANK. The bone resorption rate is therefore determined by 
the balance of RANKL and OPG (Boyle et al., 2003). A recent study has 
revealed that RANKL is highly expressed in osteocytes, which thereby have a 
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great capacity to support osteoclastogenesis (Nakashima et al., 2012). 
Additionally, mice with osteocytes that lack RANKL exhibit a severe 
osteopetrotic phonotype (Nakashima et al., 2011). Our real-time RT-PCR 
analysis showed increased expression level of RANKL despite no significant 
alteration of OPG expression in Cas cKO mice (Figure 2.6A).  This suggests 
that the high RANKL/OPG ratio favors the enhanced bone resorption in Cas 
cKO mice as compared with the control mice, consistent with our 
histomorphometric analysis in which Cas cKO mice exhibited a significant 
increase in parameters of osteoclastic bone resorption (Figure 2.5A). In 
addition, the results from our in vitro studies were consistent with our in vivo 
observations of increased RANKL expression and unaltered expression of 
sclerostin and OPG in Cas cKO mice. Cas-knockdown increased RANKL 
expression in MLO-Y4 osteocyte-like cells (Figure 2.6B), while the 
expression level of sclerostin and OPG remained unchanged upon silencing of 
Cas (Figure 2.6B).  
 
2.3.3 NF-κB p65 Promotes RANKL Expression in Osteocytes 
Since we postulated that the Cas-NF-κB interplay in osteocytes might play a 
significant role in regulating bone metabolism, we examined whether NF-κB 
was involved in the increased RANKL expression in osteocytes from Cas 
cKO mice and Cas-silenced MLO-Y4 cells.  
To dissect the role of NF-κB in the regulation of RANKL expression 
in osteocytes, we generated p65-knockdown MLO-Y4 cells using a retroviral 
system (Figure 2.7A). We found that p65-knockdown reduced RANKL 





Y4 cells, which exhibited an increased expression level of RANKL (Figure 
2.7B). These results indicate that NF-κB p65 promotes RANKL expression in 
osteocytes. 
 
Figure 2.7 Silencing NF-κB p65 attenuates RANKL expression in 
MLO-Y4 osteocytes. 
(A) The expression level of p65 in MLO-Y4 cells infected with p65-
shRNA-expressing retrovirus was evaluated by immunoblot analysis.  
(B) The mRNA expression levels of sclerostin, OPG, and RANKL 
genes in MLO-Y4 cells transduced with sh-p65 retrovirus. Error bars 
denote s.d. *: p<0.05; NS: not significant. 
 
2.3.4 Cas-NF-κB Interaction in Osteocytes 
The positive correlation between the expressions of NF-κB p65 and RANKL 
in MLO-Y4 cells (Figure 2.7) was in line with our hypothesis on the role of 
the Cas-NF-κB interplay in osteocytes. We therefore tested if the Cas-NF-κB-
p300 interaction, which we demonstrated by co-expression of exogenous 
genes in HEK293 cells (Figure 1.13), was observed in osteocytes. The Cas-
silenced MLO-Y4 cells exhibited higher level of p65 acetylation when 
compared to control-shRNA-expressing cells (Figure 2.8A). Furthermore, both 
Cas and NF-κB p65 were associated with acetyltransferase p300 in MLO-Y4 






association (Figure 2.8B, lane 3). These results suggest that Cas associates 
with p300 and that Cas and p65 interferes with each other in terms of their 
binding to p300, consistent with our previous observation of the Cas-NF-κB-
p300 interaction in HEK293 cells (Figure 1.13).  We believe that the detection 
of endogenous protein interactions (Figure 2.8B), rather than those between 
exogenously expressed molecules (Figure 1.13), strengthens the physiological 










Figure 2.8 Cas-NF-κB-p300 interation in osteocytes. 
(A) Cas expression and p65 expression/modification in MLO-Y4 cells 
infected with Cas-shRNA-expressing retrovirus were quantified by 
immunoblot analysis. Note that the acetylation level of NF-κB p65 was 
increased by Cas-knockdown. 
(B) Co-immunoprecipitation to detect Cas-NF-κB-p300 interaction in 
MLO-Y4 osteocytes. MLO-Y4 cells were lysed and subjected to anti-
p300 immunoprecipitation followed by SDS-PAGE and sebsequent 
anti-p65, anti-Cas and anti-p300 immunoblotting.  Equivalent portions 
from each sample were directly subjected to SDS-PAGE followed by 
immunoblotting. Anti-IgG was used as a negative control for 
immunoprecipitation. 
 







In osteocytes, NF-κB p65 expression positively correlated with RANKL 
expression (Figure 2.7) and the Cas-NF-κB-p300 interaction appeared to 
operate (Figure 2.8B). We then addressed the possibility that NF-κB directly 
transactivated the RANKL expression. When we conducted a CHIP 
(chromatin immuoprecipitation) analysis on MLO-Y4 cells, either Cas-
silenced (shCas) or not (Control), we did not detect the association of NF-κB 
p65 with the promoter region of RANKL (Figure 2.9, lanes 1 and 2). By 
contrast, we observed the DNA-binding activity of NF-κB to the TNF-α 
promoter region and the effect of Cas silencing on it (Figure 2.9, lanes 3 and 
4). These results favor the notion that RANKL is not a direct transcriptional 











Figure 2.9 NF-κB p65 binding to the RANKL promoter region is not 
detectable. 
ChIP analysis on NF-κB p65 subunit binding to the RANKL and TNF-α 
promoter. MLO-Y4 cells were incubated with formadehyde and cross-
linked chromatin was isolated and immunoprecipitated using anti-p65, 
anti-Polyermearase III (Pol, positive control) and anti-IgG (negative 
control) antibodies. DNA recovered from immunoprecipitation was 






2.3.6 Linkage between Cas-NF-κB Interplay and RANKL Expression in 
Osteocytes: the Implications of ROS 
2.3.6.1 ROS Production Is Involved in Cas-Mediated RANKL Expression 
in Osteocytes 
Because it appeared unlikely that NF-κB directly transactivated RANKL 
expression (Figure 2.9), we sought the mechanism behind the increased 
RANKL expression in Cas-depleted osteocytes with particular reference to 
NF-κB. Increased intracellular ROS has been reported to enhance RANKL 
mRNA and protein expression in cells of the osteoblastic lineage (Wauquier et 
al., 2009). We therefore examined whether ROS was involved in the increase 
in RANKL expression in Cas-silenced MLO-Y4 cells.  When we measured the 
intracellular ROS levels by measuring the DCF fluorescence, we found that it 
was increased in Cas-silenced MLO-Y4 cells (Figures 2.10A and 2.10B). 
Furthermore, treatment with NAC (N-acetyl cysteine), an antioxidant, almost 
completely abolished the increase in RANKL expression upon Cas silencing 
in MLO-Y4 cells (Figure 2.10C).  These results suggest that ROS production 






























Figure 2.10 ROS production is involved in the increased RANKL 
expression in Cas-silenced osteocytes. 
(A, B) Intracellular ROS level is elevated in Cas-silenced osteocytes. 
MLO-Y4 cells infected with Cas-shRNA or control retroviruses were 
incubatedwith 2’,7’–dichlorofluorescein diacetate (DCFDA), and 
analyzed for the fluorescence intensity by flow cytometry (A).  Relative 
reactive oxygen species level is scaled with the value from sh-control 
cells (left) set at 1 (B). Error bars denote s.d. **: p<0.01. 
(C)Increased RANKL Expression by Cas-Silencing Is Abolished by an 
Antioxidant N-Acetyl-L-cysteine (NAC). MLO-Y4 cells infected with 
Cas-shRNA or control retroviruses were treated with 10 mM NAC for 
24 h. The total mRNAs were then extracted for qRT-PCR analysis. 
Relative RANKL expression level is scaled with the value from sh-
control cells without NAC treatment (the leftmost box) set at 1. Error 
bars denote s.d. **: p<0.01; NS: not significant. 
 
2.3.6.2 NF-κB Is Involved in The Increased ROS Production in Cas-
Depleted Osteocytes 
We then examined whether NF-κB was involved in the increased ROS 
production in Cas-silenced osteocytes.  To this end, we generated MLO-Y4 
cells with double-knockdown of Cas and NF-κB p65 using a retroviral system 
(Figure 2.11A). We found that silencing of p65 expression revoked the 
increases in ROS production (Figure 2.11B) and RANKL expression (Figure 
2.11C) by in Cas-silenced MLO-Y4 cells. These results suggest that the 
increased ROS production in Cas-depleted osteocytes involves the NF-κB 

















Figure 2.11 NF-κB is critical for the increased ROS production and 
RANKL expression in Cas-depleted osteocytes. 
(A) The expression levels of Cas and p65 in MLO-Y4 cells infected with 
Cas-shRNA (alone) or Cas-shRNA and p65-shRNA-expressing 
retroviruses were evaluated by immunoblot analysis.  
(B)The intracellular ROS level was analyzed by DCFDA assay. The 
MLO-Y4 cells infected with p65-shRNA or Cas-shRNA and p65-
shRNA-expressing retroviruses were stained with 20 μM DCFDA and 
subject to flow cytometer as described in Figure 2.10A. Error bars 
denote s.d. *: p<0.05; **: p<0.01; NS: not significant. 
(C) The RANKL expression levels in MLO-Y4 cells infected with Cas-
shRNA (alone) or Cas-shRNA and p65-shRNA-expressing 
retroviruses. Error bars denote s.d. **: p<0.01; NS: not significant. 
 
2.3.7 Cas Supports Mitochondrial Function and Biogenesis in Osteocytes 
We found that an increase in intracellular ROS production was responsible for 








We then asked how attenuated Cas expression led to the increased ROS 
production, and speculated that Cas might be involved in regulating the 
function of mitochondria, by far the major source of intracellular ROS, in 
osteocytes.  We found that Cas-knockdown MLO-Y4 cells exhibited lower 
mitochondrial protein content, mtDNA copy number, and intracellular ATP 
levels when compared to control-shRNA-expressing cells (Figure 2.12A). 
Furthermore, 10-week-old Cas cKO mice exhibited a reduced mtDNA copy 
number in cortical bone (Figure 2.12B). These results indicate that Cas plays a 
role in maintaining the mitochondrial function in osteocytes, and suggest that 
mitochondrial dysfunction might be involved in the modulation of osteocytes’ 
function by Cas depletion, including the increased ROS production and 








Figure 2.12 Cas supports mitochondrial function and biogenesis 
in osteocytes. 
(A) The protein content of the mitochondrial fractions (left panel), 
mtDNA copy number (center panel), and intracellular ATP levels (right 
panel) were significantly reduced by Cas-knockdown in osteocytes. 
Error bars denote s.d. *: p<0.05. 
(B) mtDNA copy number in the osteocyte fractions derived from Cas 
cKO mice was significantly reduced. Error bars denote s.d. *: p<0.05. 
 
2.3.8 The Cas-NF-κB-ROS-Mitochondria-RANKL Axis 
A B 





2.3.8.1 Cas-Mediated Down-Regulation of RANKL Expression Involves 
Mitochondrial Function 
The increased ROS production and the impaired function/biogenesis of 
mitochondria observed in Cas knockdown MLO-Y4 cells suggest that 
mitochondrial dysfunction is responsible for the increased RANKL expression 
in Cas-depleted osteocytes. When we treated MLO-Y4 cells with a 
mitochondrial inhibitor, chloramphenicol (Figure 2.13A), not only 
intracellular ATP level was enhanced (Figure 2.13B) and RANKL expression 
was increased (Figure 2.13C), but also the effect of Cas knockdown on ATP 
production and RANKL expression was abolished (Figure 2.13B and 2.13C), 
supporting the notion that mitochondrial dysfunction was involved in the 


























Figure 2.13 Mitochondrial dysfunction leads to an increase in 
RANKL expression in MLO-Y4 cells.  
(A) mtDNA copy numbers in both the sh-Control and sh-Cas MLO-Y4 
osteocytes were significantly reduced when treated with 
chloramphenicol (25 ug/ml, 3 days). Error bars denote s.d. **: p<0.01; 
NS: not significant. 
(B) The intracellular ATP level in the MLO-Y4 cells infected with Cas-
shRNA or control-shRNA retroviruses in the absence or presence of 
chloramphenicol. Error bars denote s.d. **: p<0.01; NS: not significant. 
(C) Chloramphenicol treatment abolished the effect of Cas deficiency 
on RANKL expression. Error bars denote s.d. **: p<0.01; NS: not 
significant. 
 
2.3.8.2 Cas-Mediated Regulatory Effect on Mitochondrial Function 
Involves NF-κB Signaling. 
Increased ROS production appeared responsible for the increased RANKL 
















κB signaling (Figure 2.11D).  In addition, perturbation of mitochondrial 
function, the major source of intracellular ROS, led to an increase in RANKL 
expression in osteocytes (Figure 2.13C).  While these findings suggest that 
NF-κB relates to the regulation of mitochondrial function in osteocytes, NF-
κBp65 has been reported to repress mitochondrial gene expression in cardiac 
cells during the proinflammatory process (Alvarez-Guardia et al., 2010). 
Furthermore, the classical NF-κB signaling reportedly inhibits mitochondrial 
biogenesis in proliferating myoblasts, although activation of the alternative 
signaling positively regulates mitochondrial biogenesis and myotube 
maintenance (Bakkar et al., 2008). Based on our findings and these previous 
reports, we examined whether NF-κB regulated mitochondrial function, either 
positively or negatively, in osteocytes. The quantification of isolated 
mitochondria-enriched fractions revealed that mitochondrial protein content in 
p65-knockdown MLO-Y4 cells was higher than that in control-shRNA-
expressing cells (Figure 2.14). Furthermore, p65-knockdown in MLO-Y4 cells 
increased mitochondrial DNA (mtDNA) copy number and intracellular ATP 
concentration (Figure 2.14). These results indicate that NF-κB p65 negatively 
regulates mitochondrial biogenesis and function, which inversely correlated 
with RANKL expression in light of comparison between the Cas-silenced and 
the control MLO-Y4 cells (Figures 2.10 and 2.12). Furthermore, knockdown 
of p65 expression in Cas-silenced MLO-Y4 cells (Figure 2.11A) restored 
mtDNA copy number (Figure 2.14B) and abolished the regulatory effect of 
Cas on ATP production (Figure 2.14C), suggesting that Cas-mediated 
























Figure 2.14 Cas-mediated regulatory effect on mitochondrial 
function involves NF-κB. 
(A) The protein content of the mitochondrial fractions (left panel), 
mtDNA copy number (center panel), and intracellular ATP levels (right 
panel) were significantly increased in p65-knockdown MLO-Y4 cells. 
The ratio of mtDNA to nuclear DNA (nDNA) concentration was graphed 
(center panel). Error bars denote s.d. *: p<0.05. 
(B) The mtDNA copy number (center panel) in MLO-Y4 cells infected 
with Cas-shRNA (alone) or Cas-shRNA and p65-shRNA-expressing 
retroviruses were evaluated by qRT-PCR. Error bars denote s.d. *: 
p<0.05; NS: not significant. 
(C) The intracellular ATP levels in in MLO-Y4 cells infected with Cas-
shRNA (alone) or Cas-shRNA and p65-shRNA-expressing 










2.3.8.3 Tfam cKO Mice Recapitulate the Phenotype of Cas cKO Mice 
To validate the physiological relevance of our observation that impaired 
mitochondrial function is involved in the increased RANKL expression in 
osteocytes (Figure 2.12), which appeared responsible for the decreased bone 
mass in Cas cKO mice (Figure 2.14), we produced a genetically manipulated 
mice in which mitochondrial function was specifically impeded in osteocytes. 
Tfam is a ubiquitously expressed transcription factor, which is essential for 
mtDNA expression. Loss of Tfam causes depletion of mtDNA, severe 
respiratory chain deficiency, and reduced ATP production (Jeng et al., 2008; 
Miyazaki et al., 2012; Wang et al., 1999). By mating Tfamflox/flox mice with 
Dmp1-Cre transgenic mice, we generated Dmp1–Cre+/–, Tfamflox/floxmice  
(referred to herein as Tfam cKO mice).  These mice were born alive at 
predicted Mendelian frequencies; however, Tfam expression and mtDNA 
copy number were markedly reduced in osteocytes from Tfam cKO mice 
(Figure 2.15A and 2.15B). Although Tfam cKO mice grew normally with no 
apparent morphological abnormalities, 10-week-old Tfam cKO mice exhibited 
a decrease in bone mass by radiographic and µCT analysis (Figure 2.15C and 
2.15D). Histomorphometric analysis of 10-week-old Tfam cKO mice revealed 
a significant increase in the bone resorption parameters (Figure 2.15E). In 
contrast, the bone formation parameters remained unchanged when compared 
with those in normal Tfamflox/flox mice (Figure 2.15F). Collectively, Tfam cKO 
recapitulate the phenotype of Cas cKO mice, supporting the notion that the 
mitochondrial dysfunction mediates the modulation of osteocytes’ function by 
Cas depletion and that the Cas-NF-κB-mitochondria axis in osteocytes plays a 
































Figure 2.15 Generation and skeletal analysis of Tfam cKO mice. 
(A) Expression of Tfam was markedly reduced in the osteocyte 
fractions derived from Tfam cKO mice.  
(B) mtDNA copy number in the osteocyte fractions derived from Tfam 
cKO mice was markedly reduced. Error bars denote s.d. **: p<0.01. 
(C and D) Representative radiography images of the femur (c) and 
distal femur µCT (d) of male Tfam cKO mice and their normal 
Tfamflox/flox littermates at 10 weeks of age. Arrows in (C) point to 
apparent differences in bone density observed between them. Scale 
bar, 1000 μm.  
(E) Bone volume and parameters for osteoclastic bone resorption in 
the bone morphometric analysis of male Tfam cKO mice and their 
normal Tfamflox/flox littermates at 10 weeks of age (n = 5). Error bars 
denote s.d. *: p<0.05.  
(F) Bone volume and parameters for osteoblastic bone formation in the 
bone morphometric analysis of male Tfam cKO mice and their normal 
Tfamflox/flox littermates at 10 weeks of age (n = 5). Error bars denote s.d. 
NS: not significant. 
 
2.3.9 Shear Stress Enhances Nuclear Distribution of Cas  
Mechanical stress is an important regulatory factor of bone metabolism. As 
described in 2.1.7, it is postulated that when bone is subjected to dynamic 
mechanical loading, shear stress is exerted on osteocytes, which plays a major 
role in the mechanosensing function of bone (Fritton and Weinbaum, 2009; Lu 
et al., 2012). Expecting a mechano-responsive role of Cas in osteocytes, we 
conducted shear stress experiments using MLO-Y4 cells.  
We first examined whether shear stress modulated nuclear distribution 
of Cas, which was required to suppress NF-κB activity (Figure 1.11).  
Immunofluorescence staining analysis revealed that nuclear distribution of Cas 
was enhanced by shear stress (1 Pa, 10 min) in MLO-Y4 osteocytes (Figure 









Figure 2.16 Cas accumulates in the nucleus upon shear stress.  
(A) Anti-Cas immunofluorescence staining was performed to analyze 
Cas distribution in cells, either left static or subjected to shear stress.  
To visualize the nuclear regions, DAPI staining was also performed. 
Scale bar: 50 µm. 
(B) Quantitative analysis of nuclear Cas responding to shear stress as 
described in Fig. 2.16 (A). Error bars denote s.d. **: p<0.01. 
 
 
2.3.10 Cas Mediates Attenuation of p65 Acetylation by Shear Stress in 
Osteocytes  
Since nuclear distribution of Cas was enhanced upon shear stress (Figure 2.16), 
we next asked whether this increase of nuclear Cas played a role in the 
regulation of NF-κB activity. Because bone volume has been reported to be 
maintained or increased by mechanical stimulation of <100 times with a short 
duration per day (Rubin CT and Lanyon LE, 1984), we determined the 
regimen of the shear stress application as 1 Pa, 1 Hz for 10 min.  
We observed a significant decrease in the acetylation of NF-κB p65 
subunit in MLO-Y4 cells subjected to the fluid shear stress (Figure 2.17A, 
2.17B and 2.17C). However, shear stress did not decrease, but even increased 
the p65 acetylation in Cas-silenced MLO-Y4 cells (Figure 2.17A, 2.17B and 







2.17C), suggesting that Cas plays a key role in the shear stress-dependent 
attenuation of p65 acetylation in osteocytes. Consistently, the fluid shear stress 
suppressed RANKL expression (Figure 2.17D, left columns), and such 
suppressive effect of shear stress on RANKL expression was abolished by Cas 
silencing (Figure 2.17D, right columns), suggesting a pivotal role of Cas in the 





















Figure 2.17 Cas mediates in osteocytes’ responses to shear 
stress.  
(A) Anti-acetylated-p65and anti-p65 immunofluorescence staining was 
performed to analyze p65 acetylation in MLO-Y4 cells, either left static 
or subjected to shear stress. DAPI staining was also performed to 
visualize the nuclear regions. Scale bar: 50 µm. 
(B) Quantitative analysis of Fig. 2.17A. Error bars denote s.d. *: p<0.05; 
**: p<0.01; NS: not significant. 
(C) Immunoblot analysis of MLO-Y4 cells infected with sh-Cas-shRNA- 
and sh-control-shRNA-expressing retroviruses MLO-Y4 cells, either left 
static or subjected to shear stress. The numbers indicate the fold 
change of relative acetylation level of p65 repect to lane 1. 
(D) The RANKL expression levels in MLO-Y4 cells infected with Cas-
shRNA or control-shRNA in the absence or presence of shear stress. 






Our study has identified a novel function of Cas in the context of bone 
homeostasis. We demonstrated that Cas is distributed in the nucleus where it 
impedes the acetylation of NF-κB p65 by interfering with its association with 
the acetyltransferase p300 in osteocytes. This subsequently inhibits, and 
impairs the transcriptional activity of classical NF-κB. Our study provided 
evidence for the role of Cas-NF-κB-mitochondria axis in bone metabolism by 
demonstrating that it regulates RANKL expression in osteocytes (Figure 2.18). 
 
 
Figure 2.18 Summary of the Cas-NF-κB-mitochondria axis in bone 
metabolism. 
 
Recent studies have shown that NF-κB activation is involved in the 
regulation of mitochondrial function and biogenesis. While mice deficient in 
the components of the alternative NF-κB pathway, IKKα or RelB, showed 
reduced mitochondrial content and function in muscle, overexpression of these 
components in skeletal muscle stimulated the mitochondrial biogenesis 





classical NF-κB signaling inhibited the regulators of mitochondrial function 
(Mariappan et al., 2010).  While this suggests that NF-κB p65 negatively 
regulates mitochondrial function, we also demonstrate, by RNAi depletion, 
that p65 has an adverse impact on the maintenance of mitochondrial mass. 
Although the mechanism by which p65 inhibits mitochondrial function 
remains unclear, it has been reported that NF-κB p65 directly represses the 
peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1γ 
activity, thereby leading to the dysregulation of glucose oxidation in 
mitochondria (Alvarez-Guardia et al., 2010). In addition, NF-κB p65 is 
transported into the mitochondria where it associates with mtDNA and 
represses mitochondrial gene expression, oxygen consumption, and cellular 
ATP levels (Johnson et al., 2011). These previous reports are in line with our 
findings that p65 is a negative regulator for mitochondrial function.  
Previous studies have revealed that osteocytes are not ‘quiet’, but 
rather they provide a major source of RANKL that promotes 
osteoclastogenesis and tightly regulate the response of bone to mechanical 
loading/unloading (Schaffler et al., 2014). Although mechanical stretching by 
1% has been shown to induce RANKL expression in cultured osteocytes 
(Nakashima et al., 2011), it is unlikely that osteocytes, embedded in stiff bone 
matrix, undergo such a magnitude of deformation in vivo. Because shear stress, 
which is deemed a ‘physiological’ mechanical stress on osteocytes from 
computer simulation, exhibited opposing effects on p65 acetylation between 
Cas-silenced osteocytes and their control cells (Figure 2.17), Cas may play a 





Given the roles of Cas and NF-κB in cellular responses to substrate 
stiffness (Ishihara et al., 2013; Kostic and Sheetz, 2006), we speculate that 
adhesion to stiff bone matrix itself, without any additional mechanical 
perturbations, may provide osteocytes with a condition where they are prone 
to NF-κB activation followed by impaired mitochondrial function and 
subsequent increase in RANKL expression. Susceptibility to NF-κB activation 
caused by adhesion to a stiff matrix may trigger the first step in bone 
remodeling (Karsenty and Wagner, 2002; Parfitt, 1994), which is the induction 
of osteoclastic differentiation. Cas expression in osteocytes may counteract 
these NF-κB-dependent effects, leading to amelioration of bone resorption.  
Similar to Cas cKO mice, Tfam cKO mice exhibit decreased bone 
mass with increased osteoclastic bone resorption (Figure 2.15). These in vivo 
observations strongly support the notion that Cas acts as a positive regulator of 
mitochondrial function. Since human aging accompanies aberrant NF-κB 
activation and reduced mitochondrial function/biogenesis, dysfunction of Cas 
may be involved in age-related diseases including osteoporosis and sarcopenia. 
This idea is consistent with previous finding that depletion of Cas expression 
leads to defects in myogenic differentiation and the formation of 
multinucleated myotubes, both of which are typical remarks in sarcopenia 








Although the nuclear distribution of Cas has been reported in human tumor 
tissues, its physiological role or significance remains enigmatic. Here we show 
a distinct function of nuclear Cas in the inhibition of NF-κB activity, while the 
mechanism regulating Cas’ shuttling between the cytosol and the nucleus is 
yet to be elucidated.  
In the present study, we describe a novel role of the Cas-NF-κB-
mitochondria axis in maintaining bone homeostasis. Our findings reveals that 
Cas supports mitochondrial function at least partly by alleviating the NF-κB 
activity. Further research is needed to examine whether amino acids 672-738 
of Cas are sufficient to regulate mitochondrial biogenesis. 
Our present study is limited to bone remodeling and osteocyte function. 
While both Cas and NF-κB are ubiquitously expressed, Cas-mediated 
suppression of NF-κB activity may be broadly relevant to homeostasis of other 
tissues, including muscle and blood vessel. Further studies are required to 
reveal the potential impact of the Cas-NF-κB interplay on the functional 
regulation of other organs. We expect that a better understanding of Cas 
function in tissue homeostasis will help develop therapeutic strategies for NF-
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